Clinical Trials Browser

Phase 2 × Adenocarcinoma × EC145 × Clear all

NCT01002924 2021-04-08

Extension Study of EC145 (Vintafolide) for Subjects Enrolled in a Previous Study With EC145 (MK-8109-010)

Phase 2 Completed

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT01577654 2021-04-01

TARGET

Phase 2 Completed

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

NCT00511485 2015-02-27

Study of Vintafolide (MK-8109, EC145) in Participants With Progressive Adenocarcinoma of the Lung (MK-8109-008, EC-FV-03)

Phase 2 Completed

Adenocarcinoma of Lung, Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasms